Dr. Claire Clelland

MD, PhD- Assistant Adjunct Professor, Weill Institute for Neurosciences, University of California San Francisco

Dr. Clelland is a neurologist who cares for patients with dementia and cognitive decline, including mild cognitive impairment, Alzheimer's disease, frontotemporal dementia and Lewy body dementia. She specializes in supporting patients with genetic mutations linked to dementia and amyotrophic lateral sclerosis (ALS), both before and after they have symptoms. 

Clelland's research focuses on developing new therapies for neurodegenerative diseases, including frontotemporal dementia, Alzheimer's disease and ALS. She studies cells and tissues donated by patients to understand these complex conditions and develop targeted therapies. Her lab is currently developing CRISPR gene editing therapies for ALS and dementias associated with genetic mutations.